sodium 3,5-dibromo-2-hydroxybenzoate | 79427-99-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: sodium 3,5-dibromo-2-hydroxybenzoate
• 英文别名: 3,5-dibromo-2-hydroxy-benzoic acid ; sodium-salt；3,5-Dibrom-2-hydroxy-benzoesaeure; Natrium-Salz；sodium;3,5-dibromo-2-hydroxybenzoate
• CAS: 79427-99-9
• 化学式: C₇H₃Br₂O₃*Na
• 分子量: 317.897
• InChiKey: QFPJMYAAWXLIPY-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.72
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  60.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  sodium 3,5-dibromo-2-hydroxybenzoate 在 溶剂黄146 、 sodium nitrite 作用下， 以8.9%的产率得到2,4-二溴-6-硝基苯酚
  参考文献：
  名称：

  Rearrangements during nitrosodecarboxylation of isomeric dibromohydroxybenzoic acids

  摘要：

  The reaction of 3,5-dibromo-4-hydroxybenzoic acid, its sodium salt, and also sodium 3,5-dibromo-2-hydroxybenzoate with NaNO2 in a glacial acetic acid at room temperature led to the formation of a mixture of dibromonitrophenol resulting from nitrosodecarboxylation accompanied by a rearrangement processes and followed by oxidation of the arising nitrosophenols.

  DOI：

  10.1134/s1070428008050084

文献信息

• An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant
  申请人：INTERx RESEARCH CORPORATION

  公开号：EP0036534A1

  公开（公告）日：1981-09-30

  A drug form is provided for increasing the oral absorption of β-lactam antibiotics such as the penicillins, cephalosporins and related chemical species by the oral administration of said β-lactam antibiotics in a suitable pharmaceutically accepted excipient to which has been added a hydroxy aryl or hydroxy aralkyl acid or salt, amide or ester thereof. The hydroxyaryl or hydroxyaralkyl acid or salt, amide or ester thereof is present in the drug form in quantities sufficient to be effective in enhancing the rate of oral absorption of the β-lactam antibiotic.

  本发明提供了一种药物形式，通过将β-内酰胺类抗生素口服于适当的药学上可接受的赋形剂中，并在赋形剂中加入羟基芳基或羟基芳烷基酸或其盐、酰胺或酯，从而增加β-内酰胺类抗生素如青霉素类、头孢菌素类及相关化学物质的口服吸收。羟基芳基或羟基烷基酸或其盐、酰胺或酯在药物形式中的含量足以有效提高 β-内酰胺类抗生素的口服吸收率。
• An orally administered drug form comprising a polar bioactive agent and an adjuvant
  申请人：INTERx RESEARCH CORPORATION

  公开号：EP0036145A1

  公开（公告）日：1981-09-23

  A drug form is provided for increasing the oral absorption of polar bioactive agents such as xanthines, polyhydroxylic substances, zwitterions, polypeptides and organic anions and related chemical species by the oral administration of said polar bioactive agents in a suitable pharmaceutically accepted excipientto which has been added a hydroxyaromatic, hydroxyaryl or hydroxy aralkyl acid or salt amide or ester thereof. The hydroxy aryl or hydroxy aralkyl acid or salt amide or ester thereof is present in the drug form in quantities suffi- cientto be effective in enhancing the rate of oral absorption of the polar bioactive agents.

  本发明提供了一种药物剂型，用于增加极性生物活性剂（如黄嘌呤、多羟基物质、 齐聚物、多肽和有机阴离子及相关化学物质）的口服吸收，方法是将所述极性生物活性 剂口服在一种适当的药学上可接受的赋形剂中，在赋形剂中添加羟基芳基、羟基芳基或 羟基烷基酸或其酰胺盐或酯。羟基芳基或羟基烷基酸或其酰胺盐或酯在药物形式中的存在量足以有效提高极性生物活性剂的口服吸收率。
• An orally administered drug form comprising a glycosidic antibiotic and an adjuvant
  申请人：INTERx RESEARCH CORPORATION

  公开号：EP0035770B1

  公开（公告）日：1986-12-30
• A rectally administered suppository comprising a drug and an adjuvant
  申请人：Merck & Co., Inc.

  公开号：EP0031561B1

  公开（公告）日：1985-04-10
• Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
  申请人：TEIJIN LIMITED

  公开号：EP0037943B1

  公开（公告）日：1985-08-14